I first bought 10 shares of Gilead in March 2016 but the price has pulled back off considerably. After a recent weak quarter result, Gilead's stock price is now at a level which I think is even more attractive. However for the next few months, the whole biotech sector will still be challenging because of election politics. I predict this weakness will blow over eventually and I'm willing to wait while earning almost 2% dividend.
This purchase will add $20 dividend income to my dividend stock portfolio
Market CAP: 119B EPS:$11.69 Dividend: $1.72 (1.93%)
No comments:
Post a Comment